However, insulin resistance, amyloid β (Aβ) deposition, and hyperphosphorylation of Tau lead to disruption of cerebral insulin signaling (60), which may account for the higher risk of dementia and reduced local efficiency of the parahippocampal gyrus node in patients with T2DM. The gene discussed is MAPT; the disease is dementia.